Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1986374

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1986374

CAUTI Prevention Urology Products Market Size, Share & Trends Analysis Report By Product (Preventive Drainage Devices (Primary Prevention), Sterile Circuit & Maintenance Systems), By Application, By End-Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

CAUTI Prevention Urology Products Market Summary

The global CAUTI prevention urology products market size was valued at USD 3.43 billion in 2025 and is projected to reach USD 6.05 billion by 2033, growing at a CAGR of 7.35% from 2026 to 2033. The market is driven by the rising incidence of catheter-associated urinary tract infections and increasing awareness of infection control in healthcare settings.

Strict regulatory guidelines and hospital initiatives to reduce hospital-acquired infections are accelerating the adoption of antimicrobial and safety-enhanced urology products. Growing hospitalization rates, an aging population, and expanded use of urinary catheters in acute and long-term care further support market growth. The rising incidence of CAUTIs and other hospital-acquired infections is a key driver of the CAUTI prevention urology products market.

Increased awareness of patient safety, coupled with the clinical and financial impact of prolonged hospital stays, is pushing healthcare providers to prioritize infection prevention. This has accelerated demand for advanced urology products such as antimicrobial catheters, closed drainage systems, and catheter management solutions designed to reduce infection risk. According to the National Healthcare Safety Network (NHSN), about 12%-16% of adult hospital patients use an indwelling urinary catheter at some point during their hospital stay. Each additional day the catheter remains in place increases the patient's risk of developing a catheter-associated urinary tract infection (CAUTI) by 3%-7%.

As CAUTI cases rise, healthcare facilities face higher patient morbidity, longer hospital stays, and increased treatment costs. To mitigate these risks, hospitals and care providers adopt infection-prevention urology products such as antimicrobial catheters, closed drainage systems, catheter securement devices, and alternative bladder management solutions. The growing need to reduce infection rates and comply with clinical guidelines directly fuels the demand and innovation in the CAUTI prevention market.

Urinary incontinence significantly drives the CAUTI prevention urology products market by increasing catheter use across hospitals, care homes, and home care settings, thereby increasing the risk of catheter-associated urinary tract infections. The resulting clinical complications, longer hospital stays, and increased healthcare costs are prompting providers to adopt CAUTI prevention strategies, such as antimicrobial catheters, closed drainage systems, and non-invasive bladder management alternatives, to improve outcomes and reduce infection rates. According to the Urology Foundation, an estimated 5 million people in England currently live with an overactive bladder, and this number is projected to increase to more than 7 million by 2035.

Global CAUTI Prevention Urology Products Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global CAUTI prevention urology products market report on the basis of product, application, end use and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Preventive Drainage Devices (Primary Prevention)
    • Intermittent (Single-Use) Catheters
    • Antibacterial/Antimicrobial-Coated
    • Compact/Travel Intermittent
    • External (Non-Invasive) Collection Systems
    • Indwelling (Foley) Catheters
    • Silver-Alloy Coated Foley
    • Silicone-Only Foley
    • Drug-Eluting Catheters
  • Sterile Circuit & Maintenance Systems (Mechanical Prevention)
    • Closed Drainage Bags
    • Anti-Reflux Systems
    • Urine Meters
    • Catheter Stabilization/Securement Devices
    • Needleless Sampling Ports
  • Procedural Support & "Insertion Bundles" (Aseptic Prevention)
    • Pre-Packaged Aseptic Trays
    • Bladder Scanners (Portable Ultrasound)
    • Sterile Lubricant & Cleansing Solutions
  • Application Outlook (Revenue, USD Million; 2021 - 2033)
  • Urinary Incontinence Management
  • Acute Surgical/Perioperative Care
  • Benign Prostatic Hyperplasia (BPH) and Obstructive Urology
  • Neurogenic Bladder & Spinal Cord Injury (SCI)
  • End Use Outlook (Revenue, USD Million; 2021 - 2033)
  • Hospitals
  • Long Term Care Facilities
  • Home Care Setting
  • Ambulatory Surgical Centers (ASCs)
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-849-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. CAUTI Prevention Urology Products Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing use of urinary catheters in healthcare
      • 3.2.1.2. Greater focus on infection prevention in healthcare
      • 3.2.1.3. Innovation in product design and material
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of advanced catheters
      • 3.2.2.2. Lack of awareness in certain settings
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growth in home healthcare adoption
      • 3.2.3.2. Rising awareness of infection prevention
      • 3.2.3.3. Emerging markets and developing regions
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Reimbursement challenges
  • 3.3. CAUTI Prevention Urology Products Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. CAUTI Prevention Urology Products Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global CAUTI Prevention Urology Products Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global CAUTI Prevention Urology Products Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Preventive Drainage Devices (Primary Prevention)
    • 4.4.1. Preventive drainage devices (primary prevention) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Intermittent (single-use) catheters
      • 4.4.2.1. Intermittent (single-use) catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Antibacterial/antimicrobial-coated
        • 4.4.2.2.1. Antibacterial/antimicrobial-Coated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Compact/travel intermittent
        • 4.4.2.3.1. Compact/travel intermittent market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. External (non-invasive) collection systems
      • 4.4.3.1. External (non-invasive) collection systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Indwelling (foley) catheters
      • 4.4.4.1. Indwelling (foley) catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.4.2. Silver-alloy coated foley
        • 4.4.4.2.1. Silver-alloy coated foley market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.4.3. Silicone-only foley
        • 4.4.4.3.1. Silicone-only foley market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.4.4. Drug-eluting catheters
        • 4.4.4.4.1. Drug-eluting catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Sterile circuit & maintenance systems (mechanical prevention)
    • 4.5.1. Sterile circuit & maintenance systems (mechanical prevention) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Closed drainage bags
      • 4.5.2.1. Closed drainage bags market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.2. Anti-reflux systems
        • 4.5.2.2.1. Anti-reflux systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.3. Urine meters
        • 4.5.2.3.1. Urine meters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Catheter stabilization/securement devices
      • 4.5.3.1. Catheter stabilization/securement devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Needleless Sampling Ports
      • 4.5.4.1. Needleless sampling ports market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Procedural Support & "Insertion Bundles" (Aseptic Prevention)
    • 4.6.1. Procedural support & "insertion bundles" (aseptic prevention) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Pre-packaged aseptic trays
      • 4.6.2.1. Pre-packaged aseptic trays market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Bladder Scanners (Portable Ultrasound)
      • 4.6.3.1. Bladder scanners (portable ultrasound) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Sterile lubricant & cleansing solutions
      • 4.6.4.1. Sterile lubricant & cleansing solutions market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. CAUTI Prevention Urology Products Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global CAUTI Prevention Urology Products Market: Application Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global CAUTI Prevention Urology Products Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
  • 5.4. Urinary Incontinence Management
    • 5.4.1. Urinary incontinence management market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Acute Surgical/Perioperative Care
    • 5.5.1. Acute surgical/perioperative care market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Benign Prostatic Hyperplasia (BPH) and Obstructive Urology
    • 5.6.1. Benign prostatic hyperplasia (BPH) and obstructive urology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Neurogenic Bladder & Spinal Cord Injury (SCI)
    • 5.7.1. Neurogenic bladder & spinal cord injury (SCI) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. CAUTI Prevention Urology Products Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global CAUTI Prevention Urology Products Market: End use Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Global CAUTI Prevention Urology Products Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Long Term Care Facilities
    • 6.5.1. Long term care facilities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Home Care Setting
    • 6.6.1. Home care setting market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ambulatory surgical centers (ASCs)
    • 6.7.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. CAUTI Prevention Urology Products Market: Regional Estimates & Trend Analysis by Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. Reimbursement scenario
      • 7.3.2.5. U.S. CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Reimbursement scenario
      • 7.3.3.5. Canada CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Reimbursement scenario
      • 7.3.4.5. Mexico CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Reimbursement scenario
      • 7.4.2.5. UK CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Reimbursement scenario
      • 7.4.3.5. Germany CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Reimbursement scenario
      • 7.4.4.5. France CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Reimbursement scenario
      • 7.4.5.5. Italy CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Reimbursement scenario
      • 7.4.6.5. Spain CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Reimbursement scenario
      • 7.4.7.5. Sweden CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Reimbursement scenario
      • 7.4.8.5. Denmark CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Reimbursement scenario
      • 7.4.9.5. Norway CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. China CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Japan CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. India CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Reimbursement scenario
      • 7.5.5.5. South Korea CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Reimbursement scenario
      • 7.5.6.5. Australia CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. Thailand CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Brazil CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Argentina CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East and Africa
    • 7.7.1. Middle East and Africa CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. South Africa CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Saudi Arabia CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. UAE CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Kuwait CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. BD
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. B. Braun SE
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Coloplast
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Teleflex Incorporated
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Cook Medical
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Medtronic
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Hollister Incorporated
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. ConvaTec Group PLC
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Boston Scientific Corporation
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Cardinal Health
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Merit Medical
      • 8.5.17.1. Company overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. Medline Industries, LP.
      • 8.5.18.1. Company overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Poiesis Medical LLC
      • 8.5.19.1. Company overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-849-8

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America CAUTI prevention urology products market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 7 U.S. CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 10 Canada CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Mexico CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 13 Mexico CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Europe CAUTI prevention urology products market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 17 Europe CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Germany CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 20 Germany CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 22 UK CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 23 UK CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 25 France CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 26 France CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 27 France CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Italy CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 29 Italy CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 31 Spain CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 32 Spain CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Denmark CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 35 Denmark CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Sweden CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 38 Sweden CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Norway CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 41 Norway CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific CAUTI prevention urology products market, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 47 China CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 48 China CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 49 China CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Japan CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 51 Japan CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 52 Japan CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 53 India CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 54 India CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 55 India CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 56 South Korea CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 57 South Korea CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 58 South Korea CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Australia CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 60 Australia CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Thailand CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 63 Thailand CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 64 Thailand CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 65 Latin America CAUTI prevention urology products market, by region, 2021 - 2033 (USD Million)
  • Table 66 Latin America CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 67 Latin America CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 68 Latin America CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Brazil CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 70 Brazil CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 71 Brazil CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 72 Argentina CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 73 Argentina CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 74 Argentina CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 75 MEA CAUTI prevention urology products market, by region, 2021 - 2033 (USD Million)
  • Table 76 MEA CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 77 MEA CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 78 MEA CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 79 South Africa CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 80 South Africa CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 81 South Africa CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 85 UAE CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 86 UAE CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 87 UAE CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)
  • Table 88 Kuwait CAUTI prevention urology products market, by product, 2021 - 2033 (USD Million)
  • Table 89 Kuwait CAUTI prevention urology products market, by application, 2021 - 2033 (USD Million)
  • Table 90 Kuwait CAUTI prevention urology products market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 CAUTI prevention urology products market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 CAUTI prevention urology products - market size and growth prospects (USD million)
  • Fig. 11 CAUTI prevention urology products market: Industry Value Chain Analysis
  • Fig. 12 CAUTI prevention urology products market: Market Dynamics
  • Fig. 13 CAUTI prevention urology products market: PORTER's Analysis
  • Fig. 14 CAUTI prevention urology products market: PESTEL Analysis
  • Fig. 15 CAUTI prevention urology products market share by product, 2025 & 2033 (USD Million)
  • Fig. 16 CAUTI prevention urology products market, by product: market share, 2023 & 2030
  • Fig. 17 Preventive drainage devices (primary prevention) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Intermittent (single-use) catheters market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Antibacterial/Antimicrobial-Coated market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Compact/Travel Intermittent market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 External (Non-Invasive) Collection Systems market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Indwelling (Foley) Catheters market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Silver-Alloy Coated Foley market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 24 Silicone-Only Foley market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 25 Drug-Eluting Catheters market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 26 Sterile circuit & maintenance systems (mechanical prevention) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 27 Closed drainage bags market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Anti-reflux systems market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 29 Urine meters market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 30 Catheter stabilization/securement devices market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 31 Needleless sampling ports market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 32 Procedural support & "insertion bundles" (aseptic prevention) market share by application, 2025 & 2033 (USD Million)
  • Fig. 33 Pre-packaged aseptic trays market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 34 Bladder scanners (portable ultrasound) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 35 Sterile lubricant & cleansing solutions market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 36 CAUTI prevention urology products market, by application: market share, 2025 & 2033
  • Fig. 37 Urinary incontinence management market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 38 Acute surgical/perioperative care market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 39 Benign prostatic hyperplasia (BPH) and obstructive urology market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 40 Neurogenic bladder & spinal cord injury (SCI) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 41 CAUTI prevention urology products market share by end use, 2025 & 2033 (USD Million)
  • Fig. 42 CAUTI prevention urology products market, by end use: market share, 2023 & 2030
  • Fig. 43 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 44 Long term care facilities market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 45 Home care setting market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 46 Ambulatory surgical centers (ASCs) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 47 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 48 Regional marketplace: key takeaways
  • Fig. 49 North America CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 US CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Canada CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Mexico CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Europe CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 UK CAUTI prevention urology products market estimates and forecasts, 2021 - 2033) (USD Million)
  • Fig. 55 Germany CAUTI prevention urology products market estimates and forecasts, (2021 - 2033) (USD Million)
  • Fig. 56 France CAUTI prevention urology products market estimates and forecasts, (2021 - 2033) (USD Million)
  • Fig. 57 Italy CAUTI prevention urology products market estimates and forecasts, (2021 - 2033) (USD Million)
  • Fig. 58 Spain CAUTI prevention urology products market estimates and forecasts, (2021 - 2033) (USD Million)
  • Fig. 59 Sweden CAUTI prevention urology products market estimates and forecasts, (2021 - 2033) (USD Million)
  • Fig. 60 Denmark CAUTI prevention urology products market estimates and forecasts, (2021 - 2033) (USD Million)
  • Fig. 61 Norway CAUTI prevention urology products market estimates and forecasts, (2021 - 2033) (USD Million)
  • Fig. 62 Asia Pacific CAUTI prevention urology products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 China CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Japan CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 India CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Australia CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Latin America CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Brazil CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Argentina CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 MEA CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 South Africa CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 UAE CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Kuwait CAUTI prevention urology products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key company categorization
  • Fig. 78 Company market positioning
  • Fig. 79 Key company market share analysis, 2025
  • Fig. 80 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!